Viewing Study NCT00406757

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:07 PM
Ignite Modification Date: 2026-02-08 @ 1:11 AM
Study NCT ID: NCT00406757
Status: COMPLETED
Last Update Posted: 2017-11-13
First Post: 2006-11-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukaemia, Lymphoblastic, Acute and Lymphoma, Lymphoblastic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T-cell View
None T-ALL View
None T-LBL View
None 506U78 View
None ara-G View
None ara-GTP View
None Lymphoma View
None Leukemia View